• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The World Market for Cardiovascular Diagnostics (Markets for ECG, Imaging, Cardiac POC, Contrast Agents and Cardiac Markers)

$3,995.00 – $7,990.00

Clear
SKU: KLI5068892 Categories: Diagnostics Market Research, Medical Imaging & In Vivo Testing Pages: 180
  • Description
  • Table of Contents
  • Latest reports

Description

This report, The World Market for Cardiovascular Diagnostics, provides the reader with an overview of the global cardiac diagnostics industry and the trends driving growth. Segments within the cardiac diagnostic market include:

  • Electrocardiography including ECG testing, stress testing, Holter monitoring, event monitoring and implantable loop.
  • Cardiac imaging including non-invasive X-Ray, MRI, CT, ultrasound, and nuclear cardiography; and invasive /cardiac catheterization/angiography, intravascular ultrasound, optical coherence technology and electrophysiology.
  • Cardiac point-of-care including cholesterol testing and coagulation testing
  • Cardiac markers
  • Cardiac contrast agents and radiopharmaceuticals

For each of these segments, market size and forecast, along with compound annual growth rate is provided. Also included in the report are statistics influencing the industry, incidence of cardiac and related diseases worldwide, demographics, life expectancy, and company strategies. Information is presented as a global market. A market summary includes a total market analysis. Also included is a competitive analysis of leading cardiac diagnostic providers.

Economic conditions in several markets within the global cardiac diagnostics market remained challenging in 2012. Demand for cardiovascular diagnostics slowed during the historical period due to a weakened global economy, cost cutting measures and healthcare reform issues. However, demographics worldwide and an aging world society remain primary factors in growth. By 2020, 16 percent of the US population will be over the age of 65, up from 13% in 2010. People are also living longer, needing more health care, further fueling the market. In 1980, the US life expectancy at birth was 74 years, today the average American lives to be 78 years old.

The global cardiac diagnostic industry is a diverse and highly competitive market. It is anticipated that provider demand for cardiac diagnostic products and services will continue to rise providing opportunities for both existing market participants and emerging market participants. Manufacturers should look for ways to distinguish themselves in the marketplace by keeping abreast of key market drivers, restraints, and trends that are affecting the market and the economy as a whole. More than ever before, manufacturers are facing survival challenges in today’s marketplace while the need for innovative and safe products continues to grow.

Companies profiled in this report include:

  • Abbott Diagnostics
  • Acusphere
  • Alere
  • Analogic Corp
  • Bayer Healthcare
  • Bracco SpA
  • Cardinal Health
  • CardioDX
  • C.R. Bard
  • Danaher Corporation
  • dpiX
  • FluoroPharma Medical
  • GE Healthcare
  • Hitachi Medical Systems
  • Johnson & Johnson
  • King Pharmaceuticals
  • Lantheus Medical Imaging
  • LipScience
  • Medison America
  • Molecular Insight Pharmaceuticals
  • Nanosphere
  • PerkinElmer
  • Philips Healthcare
  • Roche Diagnostics
  • Shimadzu Corp
  • Siemens Medical Solutions
  • St Jude Medical
  • Terumo Medical
  • TomTec Imaging Systems
  • Toshiba
  • Trixell
  • Vascular Solutions
  • Vermillion
  • Volcano

Some of these companies are high stakes players in the market and control considerable market share while others are small or niche players that provide a valuable product to the global cardiac diagnostic arena. All are equally important to the market as a whole.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 21 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. Revenues represent sales of diagnostics that pertain to the cardiovascular arena. The base year for data was 2012. Historical data was provided for the years 2010 and 2011, with forecast data provided for 2012 through 2017. Compound annual growth rates (CAGRs) are provided for the 2010-2012 and 2012-2017 periods for each region and/or segment covered. Competitive analysis is provided for the year 2012. The forecasted market analysis for 2012-2017 was largely based on demographic trends, new developments, company performance trends, merger and acquisitions, and national expansion.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

Industry at a Glance

Scope and Methodology

Size and Growth of the Market

Key Issues and Trends Affecting the Market

Leading Market Participants

CHAPTER TWO: INDUSTRY OVERVIEW

Introduction

Cardiovascular Anatomy

Heart

Circulatory System

Cardiac Cycle

Coronary Circulation

Cardiac Myocytes

Molecular Contraction

Diseases of the Heart

Ischemic Heart Disease

Etiology

Pathophysiology

Atherosclerosis

Angina Pectoris

Acute Ischemia and Myocardial Infarction Chronic

Chronic Ischemic Cardiomyopathy

Sudden Cardiac Death

Diagnostic Tests

Valvular and Endocardial Diseases

Mitral Valve Disorders

Aortic Valve Disorders

Rheumatic Heart Disease

Endocarditis

Diagnostic Tests

Pericardial Diseases

Pericardial Effusion

Pericarditis

Myocardial Diseases

Myocarditis

Cardiomyopathy

Diagnostic Tests

Congenital Heart Diseases

Atrial Septal Defect

Ventral Septal Defect

Pulmonary Stenosis

Aortic Stenosis

Coarctation of the Aorta

Patent Ductus Arteriosus

Truncus Arteriosus

Transposition of the Great Arteries

Tricuspid Atresia

Congestive Heart Failure

Etiology

Diagnostic Tests

Cardiac Dysrhythmias

Diagnostic Tests

Hypertension

Risk Factors

Effects of High Blood Pressure

CHAPTER THREE: ELECTROCARDIOGRAPHY

Introduction

Market Size and Growth

CHAPTER FOUR: CARDIAC DIAGNOSTIC IMAGING

Non-Invasive Cardiac Imaging

X-Ray

MRI

Ultrasound

Computed Tomography

Electron Beam Computed Tomography

Dual Source Computed Tomography

Nuclear Cardiography

Invasive Transcatheter Cardiac Imaging

Cardiac Catheterization/Angiography Products

Intravascular Ultrasound

Optical Coherence Tomography

Electrophysiology

Market Size and Growth

Noninvasive Imaging

Invasive Transcatheter Imaging

CHAPTER FIVE: CARDIAC DIAGNOSTIC POINT OF CARE TESTING

Coagulation Testing

Cholesterol Testing

Total Cardiac Diagnostic Point-of- Care Market Size and Growth

CHAPTER SIX: CARDIAC MARKERS

Total Cardiac Markers Market Size and Growth

CHAPTER SEVEN: CARDIAC DIAGNOSTIC CONTRAST AGENTS AND RADIOPHARMACEUTICALS

Contrast Agents

Radiopharmaceuticals

Total Cardiac Diagnostic Contrast Agents and Radiopharmaceuticals Market Size and Growth

CHAPTER EIGHT: MARKET PARTICIPANTS

Summary

Abbott Diagnostics

Company Overview

Products

Acusphere

Alere, Inc

Company Overview

Products

Locations

Analogic Corp

Bayer Healthcare

Company Overview

Products

Bracco SpA

Cardinal Health

CardioDX, Inc

Company Overview

Products

C.R. Bard

Danaher Corporation

Company Overview

Products

dpiX, LLC

FluoroPharma Medical

GE Healthcare

Company Overview

Products and Services

Locations

Hitachi Medical Systems America, Inc.

Johnson & Johnson

Company Overview

Products

King Pharmaceuticals

Lantheus Medical Imaging

LipoScience, Inc

Company Overview

Products

Medison America, Inc.

Molecular Insight Pharmaceuticals, Inc.

Nanosphere, Inc.

Company Overview

Products

PerkinElmer

Philips Healthcare

Company Overview

Products and Services

Locations

Roche Diagnostics US (Div of Roche)

Company Overview

Products

Locations

Shimadzu Corp

Siemens Medical Solutions

Company Overview

Products and Services

St. Jude Medical

Company Overview

Products

Terumo Medical Corporation

TomTec Imaging Systems GmbH

Toshiba America Medical Systems, Inc

Company Overview

Products and Services

Trixell

Vascular Solutions

Vermillion, Inc

Company Overview

Products

Volcano Corp

Company Overview

Products

Locations

CHAPTER NINE: MARKET TRENDS AND SUMMARY

Market Overview

Market Revenues by Product Type

Global Cardiac Diagnostic Market Analysis by Region

United States

Europe

Japan

Rest of World

Competitive Analysis

CHAPTER TEN: INDUSTRY DEVELOPMENTS AND TECHNOLOGIES

Demographics

Cardiovascular Disease Worldwide

European Cardiovascular Disease Statistics

US-Specific Population Demographics

Population Over Age 65

Life Expectancy

Increasing Incidence of Disease

New Cardiac CT Device

CT Spots Seeds of Heart Disease in Healthy Patients

Contrast Agent Toxicity

Contrast Agents Generic Competition

MRI Catheter Guidance

Healthcare Reform

CHAPTER ELEVEN: CONCLUSIONS

LIST OF COMPANIES

LIST OF EXHIBITS

CHAPTER ONE:EXECUTIVE SUMMARY

Summary Table

Global Cardiac Diagnostics Market Analysis, 2010-2017

Summary Figure

Global Cardiac Diagnostics Market Analysis: 2010-2017

CHAPTER THREE: ELECTROCARDIOGRAPHY

Table 3-1

Total Electrocardiography Testing Market Analysis, 2010-2017

Figure 3-1

Total Electrocardiography Testing Market Analysis, 2010-2017

CHAPTER FOUR: IMAGING MARKET

Table 4-1

Non-Invasive Cardiac Imaging Market Analysis, 2010-2017

Table 4-2

Invasive Transcatheter Cardiac Imaging Market Analysis, 2010-2017

Table 4-3

Total Cardiac Diagnostic Imaging Market Analysis, 2010-2017

Figure 4-1

Total Cardiac Diagnostic Imaging Market Analysis, 2010-2017

CHAPTER FIVE: CARDIAC POINT OF CARE TESTING

Table 5-1

Cardiac Coagulation Testing Market Analysis, 2010-2017

Table 5-2

Cardiac Cholesterol Testing Market Analysis, 2010-2017

Table 5-3

Total Cardiac Diagnostic POC Testing Market Analysis, 2010-2017

Figure 5-1

Total Cardiac Diagnostic POC Testing Market Analysis, 2010-2017

CHAPTER SIX: CARDIAC MARKERS

Table 6-1

Total Cardiac Markers Market Analysis, 2010-2017

Figure 6-1

Total Cardiac Markers Market Analysis, 2010-2017

CHAPTER SEVEN: CARDIAC CONTRAST AGENTS

Table 7-1

Total Cardiac Diagnostic Contrast Agent and Radiopharmaceuticals Market Analysis,2010-2017

Figure 7-1

Total Cardiac Diagnostic Contrast Agent and Radiopharmaceuticals Market Analysis,2010-2017

CHAPTER NINE: MARKET TRENDS AND SUMMARY

Table 9-1

Global Cardiac Diagnostics Market Analysis, 2010-2017

Figure 9-1

Global Cardiac Diagnostics Market Analysis: 2010-2017

Table 9-2

Global Cardiac Diagnostics by Type Revenues and Percent of Market 2012 (in millions of dollars at the manufacturers’ level)

Figure 9-2

Global Cardiac Diagnostics by Type Revenues and Percent of Market 2012

Table 9.3

Global Cardiac Diagnostic by Type Revenues and Percent of Market 2017 (in millions of dollars at the manufacturers’ level)

Figure 9-3

Global Cardiac Diagnostics by Type Revenues and Percent of Market 2016

Table 9-4

Global Cardiac Diagnostics Market Revenues by Region 2012 ($millions)

Figure 9-4

Global Cardiac Diagnostics Market Revenues by Region 2012 ($millions)

Figure 9-5

Global Cardiac Diagnostics by Region Percent 2012 (%)

Table 9-5

Global Cardiac Diagnostics Market Revenues by Region 2017 ($millions)

Figure 9-6

Global Cardiac Diagnostics Market Revenues by Region 2017 ($millions)

Figure 9-7

Global Cardiac Diagnostics by Region Percent 2017 (%)

Table 9-6

Estimated Global Cardiac Diagnostics Manufacturer Market Share 2012

Figure 9-8

Estimated Global Cardiac Diagnostics Revenues and Market Share 2012

CHAPTER TEN: INDUSTRY DEVELOPMENTS AND TECHNOLOGIES ..165

Table 10-1

Total Global Population by Selected Geographical Region, 2000 – 2050

Table 10-2

Cardiovascular Deaths by World Region 2008

Table 10-3

The U.S. Population, 1980-2020

Figure 10-1

The US Population, 1980-2020 (in millions)

Table 10-4

Percent U.S. Population Over Age 65 by Year

Figure 10-2

Estimated Population by Age Group, 2000 and 2050

Table 10-5

Average U.S. Life Expectancy in Years 1980, 2004, 2006, 2010, 2011 (years)

Figure 10-3

Average U.S. Life Expectancy in Years 1980, 2004, 2006, 2010, 2011

APPENDIX

 

    30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025 (June 2025 Update)
    June 25, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    June 24, 2025
    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025

Related products

  • Placeholder image

    U.S. Market for Molecular Diagnostics, 2nd Edition

    $3,500.00 – $7,000.00
  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00
  • Placeholder image

    Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

    $1,500.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Out of Pocket Healthcare Spending 2013Next Generation Sequencing Trends (Clinical Applications, Systems Used, Accreditation...
Scroll to top